View Kyle's poster:

Payer Perspectives of Cell Therapy and Gene Therapy Treatment Paradigms for an Inherited Retinal Disorder

Download now

Discover more Consulting insights

Insight

Cencora PayerPulse: The unintended consequences of the Inflation Reduction Act (IRA)

AmerisourceBergen
September 2024

Download the infographic

Insight

Panel discussion: Strategically prepare for IRA Part D redesign

AmerisourceBergen
August 2024

Watch now

Insight

HTA Quarterly Fall 2024

AmerisourceBergen
August 2024

In this special themed edition, our colleagues at Vintura, a Cencora company, explore the potential of value-based partnerships (VBPs). First outlining the principles, goals and potential benefits of VBPs, this edition also provides two case studies that demonstrate how successful partnerships work in practice.

Health Policy Weekly

Health Policy weekly recaps legislative and regulatory developments and healthcare reform news that impacts the healthcare industry, particularly pharmaceutical, biotech, and device manufacturers, providers, and managed care.

Developed by a multi-disciplinary editorial board that includes health policy and reimbursement strategy experts, Health Policy Weekly delivers key insights to your inbox every week.

Subscribe to HPW

Keep up on key global health technology assessment news

HTA Quarterly

Each edition of HTA Quarterly provides insights and analysis from global experts with local market expertise on key priorities and perspectives affecting HTA.

From therapeutic area spotlights to geographic reviews to critical industry topics, keep current on HTA activity around the globe with HTA Quarterly.

Subscribe to HTAQ

We are Cencora. Our shared identity unites us.

Cencora brings the companies and services of AmerisourceBergen together under one new name. Check out our full life cycle commercialization solutions, and contact us today to learn more.

See our solutions

Connect with our team